// App-Quantinova.ai

PB0327 : Antibody-induced procoagulant platelets cause increased thrombus formation in heparin-induced thrombocytopenia

Researchers

Presenter

  • J. Zlamal

Principal Investigators

  • A. Singh

  • L. Pelzl

  • K. Althaus

Medical Centers

  • Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany, Tuebingen, Baden-Wurttemberg, Germany

  • Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany, Tuebingen, Baden-Wurttemberg, Germany

  • University Hospital of Tuebingen, Tuebingen, Germany, Tuebingen, Baden-Wurttemberg, Germany

  • Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany, Tuebingen, Baden-Wurttemberg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • P-selectin

  • Immunoglobulin G

Drug/Treatment

  • Phosphatidylserine

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved